The global Cirrhosis Management Market is expected to grow at a CAGR of 3.8% from 2022 to 2032, reaching US$ 1,059 Million. From 2016 to 21, the market grew at a compounded rate of 3.5%. The market’s expansion can be attributed to rising incidences of liver cirrhosis caused by an increase in hepatitis infections worldwide.
Cirrhosis causes the liver to shrink and harden which makes it difficult for the blood to flow into the portal vein in the liver. The liver becomes lumpy and hard and will start to fail. Basically, the liver is a hardy organ and has the ability to regenerate damaged cells. Cirrhosis develops in the liver when factors like chronic viral infections and alcohol are present for a long period of time.
When this occurs, the liver becomes scarred and injured. Cirrhosis develops as a result of the scarred liver’s inability to function properly. Cirrhosis is caused primarily by excessive alcohol consumption, hepatitis B and C, and non-alcoholic fatty liver disease.
For More Insights on this Market, Get A Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5045
There are mainly two stages of cirrhosis: compensated and decompensated. In compensated cirrhosis, there are no signs of symptoms which means there is a still presence of healthy liver cells that can meet the body needs. Whereas, decompensated cirrhosis causes symptoms such as fluid will build up in the belly (ascites), toxins will build up in the blood causing confusion, occurrence of gallstones, etc.
Chances of these problems can be reduced by keeping a healthy weight, eating a low fat diet, not smoking, sticking to the treatments, not drinking. Treatments like medications, regular doctor visits and lifestyle changes can sometimes prevent or delay the further damaging of the liver.
According to the National Institute of Health (NIH), cirrhosis is the 12th leading cause of death due to the diseases in the United States. Also it is estimated that cirrhosis occurs in 2 inpiduals per 100,000 inpiduals. Cirrhosis is more common in men than women.
Cirrhosis Management Market: Drivers and Restraints
The appropriate method for cirrhosis management is of major importance. Thus it is expected to be the prime factor driving growth of global cirrhosis management. Increasing prevalence of disease such as non-alcoholic fatty liver diseases is fueling the global cirrhosis management market growth.
Moreover, the growing geriatric population has also lead to the significant addition in the global cirrhosis management market. However the lack of low treatment rate due to absence of signs and symptoms of cirrhosis are limiting the growth of global cirrhosis management market.
Have a Conversation with the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-5045
Cirrhosis Management Market: Overview
Based on the treatment type, the global cirrhosis management market is segmented into treating cirrhosis causes, symptomatic treatment, treatment to avoid complications and liver transplantation. Based on disease indication, the global cirrhosis management market is segmented into alcoholic liver cirrhosis and non-alcoholic liver cirrhosis.
Based on end user, the global cirrhosis management market is segmented into hospitals, ambulatory surgical centers, research institutes, dialysis centers, clinics and others.
Cirrhosis Management Market: Regional Outlook
Geographically, global cirrhosis management market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to dominate global cirrhosis management market over the forecast period due to high prevalence of liver cirrhosis diseases. Western Europe is expected to be the second largest market for cirrhosis management.
Cirrhosis Management Market: Key Players
- B. Braun Medical Inc.
- Alliancells Bioscience Corporation Ltd.
- Histogen Inc.
- Stempeutics Research Pvt. Ltd.
- Epic Research & Diagnostics Inc.
- Theravance Biopharma R&D Inc.
- Sequana Medical AG
Last few days to get reports at discounted prices, the offer expires soon!
Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-5045
Cirrhosis is a condition where the liver becomes scarred due to long-term damage. It is a serious condition that can lead to liver failure and other complications. End-Stage Liver Disease Management typically involves treating the underlying cause of the disease, managing the symptoms and complications, and preventing further damage to the liver.
Key Segments Profiled In The Cirrhosis Management Industry Survey
Cirrhosis Management Market by Treatment:
- Cirrhosis Management for Treating Cirrhosis Causes
- Cirrhosis Management via Antiviral Medications for Hepatitis B & C
- Cirrhosis Management via Corticosteroids
- Cirrhosis Management via Symptomatic Treatment
- Cirrhosis Management via Analgesics
- Cirrhosis Management via Treatment of Portal Hypertension (Beta-Blockers, Nitrates)
- Cirrhosis Management via Treatment of Edema and Ascites (Diuretics, Antibiotics)
- Cirrhosis Treatment to Avoid Complications
- Cirrhosis Management via Banding Procedures/Band Ligation of Varics
- Cirrhosis Management via Dialysis
- Cirrhosis Management via Treatment of Osteoporosis
- Cirrhosis Management via Vaccination for Flu and Other Complications
- Cirrhosis Management via Liver Transplantation
Cirrhosis Management Market by Disease Indication:
- Alcoholic Liver Cirrhosis Management
- Non-Alcoholic Liver Cirrhosis Management
Cirrhosis Management Market by End User:
- Cirrhosis Management in Hospitals
- Cirrhosis Management in Ambulatory Surgical Centers
- Cirrhosis Management in Research Institutes
- Cirrhosis Management in Dialysis Centers
- Cirrhosis Management in Clinics
- Cirrhosis Management in Other Settings
The report covers exhaustive analysis on
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Have a Look at Related Research Reports in the Healthcare Domain:
- https://hulu-com-forgot.mn.co/posts/34386853
- https://viewfromabove.mn.co/posts/34386857
- https://jibonbook.com/read-blog/24505
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
